CLINICAL_TRIALS
trial_result
· 2017-04-11
Clinical Trial Update: Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial [Phase 4]
Summary
Phase 4 clinical trial evaluating teriparatide for joint erosions in rheumatoid arthritis has completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2017-04-11